MARY C BARRAZA

Allopathic & Osteopathic Physicians|Family Medicine ATTICA, IN NPI 1518320779

General Payments — all program years on this page

$1,557.24

  • Category: General Payments
  • Program years: PY2019–2023
  • Record count: 89
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $364.84 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $364.8420

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $49.304
2020 $259.6416
2021 $429.1723
2022 $454.2926
2023 $364.8420

Records — PY2023 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1002206029 Novo Nordisk Inc $13.67 03/02/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002206041 Novo Nordisk Inc $14.12 03/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002206053 Novo Nordisk Inc $15.76 05/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002206065 Novo Nordisk Inc $16.88 07/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002206075 Novo Nordisk Inc $21.98 01/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014210327 Otsuka America Pharmaceutical, Inc. $16.60 01/05/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014210335 Otsuka America Pharmaceutical, Inc. $13.09 04/04/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1016137255 AstraZeneca Pharmaceuticals LP $13.28 01/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1026593769 Exact Sciences Corporation $23.92 03/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1026593803 Exact Sciences Corporation $18.79 04/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1043897287 SANOFI PASTEUR INC. $20.56 02/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049121541 PFIZER INC. $22.81 01/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049218799 PFIZER INC. $16.00 05/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049563847 PFIZER INC. $24.32 02/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049618727 SANOFI-AVENTIS U.S. LLC $14.77 03/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057486985 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.72 03/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996210613 AbbVie Inc. $13.09 01/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996210615 AbbVie Inc. $20.98 02/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996210617 AbbVie Inc. $32.89 07/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996494525 Boehringer Ingelheim Pharmaceuticals, Inc. $14.61 06/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.